Loading…
Palisade Bio, Inc. is projected to rise to $2.03 by 2027, a +7% move from its current price of $1.90. PALI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $1.83 | $1.90 | $1.97 | +0.04% |
| Aug 4 | $1.80 | $1.90 | $2.00 | +0.08% |
| Aug 5 | $1.78 | $1.90 | $2.02 | +0.12% |
| Aug 6 | $1.76 | $1.90 | $2.04 | +0.17% |
| Aug 7 | $1.75 | $1.90 | $2.06 | +0.21% |
| Aug 8 | $1.74 | $1.90 | $2.08 | +0.25% |
| Aug 9 | $1.73 | $1.90 | $2.09 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.73 | $1.90 | $2.09 | +0.29% |
| Week 2 | $1.66 | $1.91 | $2.19 | +0.58% |
| Week 3 | $1.62 | $1.91 | $2.26 | +0.88% |
| Week 4 | $1.58 | $1.92 | $2.33 | +1.17% |
| Week 5 | $1.55 | $1.92 | $2.39 | +1.46% |
| Week 6 | $1.52 | $1.93 | $2.44 | +1.76% |
| Week 7 | $1.50 | $1.93 | $2.50 | +2.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical candidate is PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn's disease.
The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.
Palisade Bio trades at $1.90 with a market capitalization of $329.31M. It ranks 3360 in market capitalization among listed assets.
The near-term outlook shows a path of gradual upside in the forecast, with an average price of $1.90 in 2026 and higher averages projected out to 2050. Specifically, the forecast envisions an average price of $3.13 by 2030 and $9.60 by 2050, with corresponding maximums of $4.86 by 2030 and $19.96 by 2050.
A major floor 18.4% below — a decisive break under it would weaken the trend.
The nearest floor, 5.0% below — buyers have tended to step in here.
The nearest ceiling, 17.7% above — a clean break opens room to run.
A major ceiling 47.8% above — clearing it would confirm fresh momentum.
Key PALI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PALI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.97 | Sell | $1.95 | Sell |
| MA 10 | $1.96 | Sell | $1.96 | Sell |
| MA 20 | $1.97 | Sell | $1.96 | Sell |
| MA 50 | $1.93 | Sell | $1.95 | Sell |
| MA 100 | $1.97 | Sell | $1.92 | Sell |
| MA 200 | $1.92 | Sell | $1.90 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.80 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -94.07 | Neutral |
| Williams %R (14) | -92.86 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.40 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 7.14 | Buy |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 50.36 | Neutral |
| Momentum (10) | -0.07 | Sell |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 1.96 | Sell |
| ADX (14) | 5.95 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is Neutral overall. RSI14 is 50, with the price sitting between SMA50 at $1.93 and SMA200 at $1.92.
Near-term support is listed at $1.80 and resistance at $2.23. The 30-day price range is $1.49 to $2.41, indicating a relatively narrow trading band around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.49 | $1.90 | $2.39 | 0% | Neutral | |
| $1.57 | $2.03 | $2.80 | +7% | Neutral | |
| $1.56 | $2.10 | $3.05 | +11% | Neutral | |
| $2.02 | $2.80 | $4.21 | +48% | Bullish | |
| $2.19 | $3.13 | $4.86 | +65% | Bullish | |
| $1.92 | $2.83 | $4.51 | +49% | Bullish | |
| $1.98 | $2.98 | $4.87 | +58% | Bullish | |
| $2.00 | $3.09 | $5.15 | +63% | Bullish | |
| $2.10 | $3.31 | $5.63 | +75% | Bullish | |
| $2.59 | $4.18 | $7.23 | +121% | Bullish | |
| $2.71 | $4.84 | $9.03 | +155% | Bullish | |
| $4.49 | $9.60 | $19.96 | +406% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.49 | $1.90 | $2.27 | +0.00% |
| September 2026 | $1.63 | $1.95 | $2.41 | +2.89% |
| October 2026 | $1.63 | $1.97 | $2.47 | +0.94% |
| November 2026 | $1.55 | $1.88 | $2.39 | -4.27% |
| December 2026 | $1.53 | $1.87 | $2.39 | -0.83% |
Click any year to see its month-by-month PALI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PALI is projected to trade between $1.49 and $2.39, averaging $1.90 — a potential gain of 0% from today's $1.90. A consolidation phase looks the most probable path here.
Palisade Bio, Inc.'s 2027 outlook centres on $2.03, within a $1.57 to $2.80 range. That is up +7% on the projected 2026 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2028, PALI could reach as high as $3.05, with a base case around $2.10 and support toward $1.56 — roughly +11% from $1.90. A consolidation phase looks the most probable path here.
Expect PALI to range from $2.02 to $4.21 through 2029. The $2.80 average target implies a +48% move from current prices. That is up +33% on the projected 2028 average. Momentum favours further upside here.
The PALI price prediction for 2030 points to an average of $3.13 (low $2.19, high $4.86) — a potential gain of +65% on today's $1.90. Buyers look set to stay in control over this stretch.
In 2031, PALI is projected to trade between $1.92 and $4.51, averaging $2.83 — a potential gain of +49% from today's $1.90. That is -10% versus the projected 2030 average. Momentum favours further upside here.
Palisade Bio, Inc.'s 2032 outlook centres on $2.98, within a $1.98 to $4.87 range. That is up +6% on the projected 2031 average. That marks a +58% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PALI could reach as high as $5.15, with a base case around $3.09 and support toward $2.00 — roughly +63% from $1.90. Momentum favours further upside here.
Expect PALI to range from $2.10 to $5.63 through 2034. The $3.31 average target implies a +75% move from current prices. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PALI price prediction for 2035 points to an average of $4.18 (low $2.59, high $7.23) — a potential gain of +121% on today's $1.90. Momentum favours further upside here.
In 2040, PALI is projected to trade between $2.71 and $9.03, averaging $4.84 — a potential gain of +155% from today's $1.90. That is up +16% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Palisade Bio, Inc.'s 2050 outlook centres on $9.60, within a $4.49 to $19.96 range. That is up +98% on the projected 2040 average. That marks a +406% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PALI today (≈ 527.704485 PALI) could be worth
$5,064.77
+$4,064.77 (+406%) by 2050 · US Dollar
Based on the average projected PALI price of $9.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PALIwould be worth at today's price.
$1,000 invested in PALI on Jul 31, 2025 (≈ 980.392175 PALI) would be worth
$1,857.84
+$857.84 (+85.8%) today · 1.86× · US Dollar
Based on a PALI entry price of $1.02 vs. today's $1.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.95 | $971.79 | -2.8% |
| 1 month ago | $1.97 | $961.93 | -3.8% |
| 3 months ago | $1.99 | $952.26 | -4.8% |
| 6 months ago | $1.61 | $1,177.02 | +17.7% |
| 1 year ago | $1.02 | $1,857.84 | +85.8% |
| All time (5.0y) ago | $2,062.5 | $0.92 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PALI forecast.
Our base-case forecast reaches $3.80 around 2035.
Implied market cap at $3.80: $659.6M
The multi-year forecast shows bullish momentum building from 2029 onward. By 2030, the average forecast price is $3.13 with a 65.2% ROI and a bullish sentiment; the 2030 min is $2.19 and max is $4.86. By 2040, the average forecast rises to $4.84 with a 155.3% ROI and a bullish sentiment, with a min of $2.71 and a max of $9.03.
By 2050, the average forecast is $9.60 with a 406.5% ROI and a bullish sentiment, with a min of $4.49 and a max of $19.96.
These are estimates, not guarantees, and actual results may differ. The data show increasing upside potential across later years, balanced by the inherent uncertainties of clinical-stage development and regulatory outcomes.
Tap a question to reveal the answer.
The forecast shows avg $3.13, min $2.19, max $4.86; ROI 65.2%; sentiment BULLISH.
The forecast indicates a bullish trajectory with an avg price of $9.60 by 2050 and ROI of 406.5%, but these are estimates and not guarantees.
Yes—the 2050 max is $19.96, with an average of $9.60, so reaching around or above $10 is within the forecast range.
Current price is $1.90 and market cap is $329.31M.
Sentiment is NEUTRAL; RSI14 is 50. SMA50 is $1.93 and SMA200 is $1.92. 30-day range is $1.49-$2.41 with support at $1.80 and resistance at $2.23.
Palisade Bio, Inc. Community Discussion
0Share your Palisade Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.